Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401541 · ClinicalTrials.gov registry record · Early Phase 1
25-Hydroxyvitamin D Pharmacokinetic Study
A Early Phase 1 study, sponsored by Boston University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
NCT03401541 is a Early Phase 1 study that has completed, run by Boston University. The registered enrollment target is 16 participants.
The verdict
NCT03401541, a Early Phase 1 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To evaluate the pharmacokinetic parameters of orally administered 25-hydroxyvitamin D3 \[25(OH)D3\] and vitamin D3 from the corresponding serum concentration-time curves in healthy adults and adults with a history of intestinal malabsorption.
Interventions
- DRUG Calcifediol
- DRUG Calciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-11-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03401541
The ClinicalTrials.gov registry entry for NCT03401541 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Calcifediol is the first listed.
NCT03401541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03401541 about?
NCT03401541 is a clinical study titled "25-Hydroxyvitamin D Pharmacokinetic Study". To evaluate the pharmacokinetic parameters of orally administered 25-hydroxyvitamin D3 \[25(OH)D3\] and vitamin D3 from the corresponding serum concentration-time curves in healthy adults and adults with a history of intestinal malabsorption.
What is the current status of trial NCT03401541?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2018-10-01. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT03401541?
The interventions under investigation include: Calcifediol (DRUG), Calciferol (DRUG).
Who is sponsoring clinical trial NCT03401541?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.